Ixico (IXI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 7.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 20.30p
  • 52 Week Low: 7.00p
  • Currency: UK Pounds
  • Shares Issued: 48.35m
  • Volume: 110
  • Market Cap: £3.38m

Income Statement - Normalised

  £ (Millions) £ (Millions) £ (Millions)
30-Sep-11 30-Sep-10 30-Sep-09
Continuing Operations      
Revenue 0.07 0.70 0.87
       
EBITDA (8.52) (4.34) (4.00)
Depreciation & Amortisation (0.05) (0.07) (0.10)
       
Operating Profit/(Loss) (8.57) (4.41) (4.10)
Interest Payable n/a n/a n/a
Interest Receivable/Investment Income 0.38 0.29 0.18
       
Group Profit after Interest (8.20) (4.12) (3.92)
Share of Assoc Cos/JV Profits n/a n/a n/a
       
Profit Before Tax (8.20) (4.12) (3.92)
Tax 0.51 0.41 0.29
       
Profit After Tax (7.68) (3.71) (3.63)
       
Discontinued Operations      
Profit After Tax n/a n/a n/a
       
PROFIT FOR PERIOD (7.68) (3.71) (3.63)
       
Attributable to:      
Equity Holders of Parent Company (7.68) (3.71) (3.63)
Minority Interests n/a n/a n/a
       
Equity Dividends cn/a cn/a cn/a
Retained Profit/(Loss) for the Financial Year c(7.68) c(3.71) c(3.63)


Per Share Record - Normalised 30-Sep-11 30-Sep-10 30-Sep-09
Continuing EPS      
Earnings per Share - Basic (2.22p) (1.30p) (3.84p)
Earnings per Share - Diluted (2.22p) (1.30p) (3.84p)
Earnings per Share - Adjusted (110.00p) (65.00p) (155.30p)
Continuing and Discontinued EPS      
Earnings per Share - Basic (2.22p) (1.30p) (3.84p)
Earnings per Share - Diluted (2.22p) (1.30p) (3.84p)
Earnings per Share - Adjusted (110.00p) (65.00p) (155.30p)
       
Dividend per Share n/a n/a n/a


Key Financals 30-Sep-11 30-Sep-10 30-Sep-09
Shares in Issue (millions)      
Shares in Issue - Year End 346.80 346.68 94.55
Weighted Average 346.62 284.23 94.55
Diluted 346.62 284.23 94.55
       
Performance Ratios      
Continuing Operations      
Operating Margin (12,859.48%) (632.56%) (472.32%)
Return on Capital Employed n/a n/a n/a
Continuing Operations & Discontinued Operations      
Return on Equity (48.13%) (15.79%) (115.60%)
       
Financial Status      
Continuing Operations      
Interest Cover - Continuing n/a n/a n/a
Revenue per Share 0.019p 0.24p 0.92p
Pre-Tax Profit Per Share - Continuing (2.37p) (1.45p) (4.15p)
       
Market Data      
Continuing Operations      
Earnings Per Share Growth - Basic n/a n/a n/a
Earnings Per Share Growth - Diluted n/a n/a n/a
PE Ratio - Company Adjusted n/a n/a n/a
PEG - Company Adjusted n/a n/a n/a
Dividend Cover n/a n/a n/a
Continuing Operations & Discontinued Operations      
Earnings per Share - Company Adjusted n/a n/a n/a
Earnings per Share - Diluted n/a n/a n/a
PE Ratio - Company Adjusted n/a n/a n/a
PEG - Company Adjusted n/a n/a n/a
Dividend Cover n/a n/a n/a
       
Market Capitalisation £ (Millions) 1,300.51 1,461.25 183.72
Dividend per Share n/a n/a n/a
Dividend Yield 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a

Key

* GAAP

a. Includes discontinued activities

b. Includes preference dividends

c. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.

 

Top of Page